Cargando…

Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection

Predictive factors for adverse outcomes in patients with COVID-19 are urgently needed. Data related to the applicability of the Clinical Frailty Scale (CFS) for risk stratification in patients with COVID-19 are currently lacking. We investigated the ability of CFS to predict need for mechanical vent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Labenz, Christian, Kremer, Wolfgang M., Schattenberg, Jörn M., Wörns, Marcus-Alexander, Toenges, Gerrit, Weinmann, Arndt, Galle, Peter R., Sprinzl, Martin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418620/ https://www.ncbi.nlm.nih.gov/pubmed/32641351 http://dx.doi.org/10.1136/jim-2020-001410

Ejemplares similares

Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis
por: Schleicher, Eva Maria, et al.
Publicado: (2022)

Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis
por: Kremer, Wolfgang M., et al.
Publicado: (2020)

Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies
por: Labenz, Christian, et al.
Publicado: (2020)

Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2022)

Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study
por: Kremer, Wolfgang M., et al.
Publicado: (2021)

Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Labenz, Christian, et al.
Publicado: (2021)

Risk factors for poorer health literacy in patients with liver cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2021)

Metabolic dysfunction-associated fatty liver disease in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2023)

Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
por: Michel, Maurice, et al.
Publicado: (2021)

Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives
por: Nagel, Michael, et al.
Publicado: (2020)

Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment
por: Nagel, Michael, et al.
Publicado: (2023)

Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Development and evaluation of a virtual reality driving test for patients with cirrhosis
por: Gairing, Simon J., et al.
Publicado: (2023)

Health-related quality of life in patients with autoimmune hepatitis
por: Michel, Maurice, et al.
Publicado: (2021)

Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis
por: Nagel, Michael, et al.
Publicado: (2022)

Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation
por: Nagel, Michael, et al.
Publicado: (2022)

Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort
por: Steinebrunner, Niels, et al.
Publicado: (2015)

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
por: Weinmann, Arndt, et al.
Publicado: (2015)

Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B
por: Sprinzl, Martin F., et al.
Publicado: (2021)

A higher FIB‐4 index is associated with an increased incidence of renal failure in the general population
por: Schleicher, Eva Maria, et al.
Publicado: (2022)

Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
por: Kaps, Leonard, et al.
Publicado: (2022)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
por: Labenz, Christian, et al.
Publicado: (2020)

Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment
por: Grimm, Daniel, et al.
Publicado: (2016)

Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany
por: Tilch, Marie-Kristin, et al.
Publicado: (2021)

Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders
por: Gairing, Simon Johannes, et al.
Publicado: (2021)

Marginal hazard ratio estimates in joint frailty models for heart failure trials
por: Toenges, Gerrit, et al.
Publicado: (2019)

Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
por: Labenz, Christian, et al.
Publicado: (2020)

(13)C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Portal vein thrombosis is associated with an increased risk of bone fractures
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cells
por: Kohl, T, et al.
Publicado: (2013)

Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure
por: Gehrke, Nadine, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
por: Labenz, Christian, et al.
Publicado: (2020)

Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation
por: Gehrke, Nadine, et al.
Publicado: (2016)

The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease
por: Alt, Yvonne, et al.
Publicado: (2016)

Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
por: Gairing, Simon Johannes, et al.
Publicado: (2023)

High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g8u6f4k57pqo35qj3tduukkusd